4th jab. Documentation of long term negative efficacy. No dea | Robert W Malone, MD

4th jab. Documentation of long term negative efficacy. No death protection benefit.

Effectiveness of a fourth SARS-CoV-2 vaccine dose in previously infected individuals from Austria

Results: Among 3,986,312 previously infected individuals, 281,291 (7,1%) had four and 1,545,242 (38.8%) had three vaccinations at baseline. We recorded 69 COVID-19 deaths and 89,056 SARS-CoV-2 infections. rVE for four versus three vaccine doses was -24% (95% CI: -120 to 30) against COVID-19 deaths, and 17% (95% CI: 14-19) against SARS-CoV-2 infections. This latter effect rapidly diminished over time and infection risk with four vaccinations was higher compared to less vaccinated individuals during extended follow-up until June 2023. Adjusted HR (95% CI) for all-cause mortality for four versus three vaccinations was 0.79 (0.74-0.85).

Discussion: In previously infected individuals, a fourth vaccination was not associated with COVID-19 death risk, but with transiently reduced risk of SARS-CoV-2 infections and reversal of this effect in longer follow-up.

All-cause mortality data suggest healthy vaccinee bias.

https://pubmed.ncbi.nlm.nih.gov/38032853/

Follow and Share
@RWMaloneMD